BLRX

BioLineRX
BLRX

Overview Fund Activity

24 hedge funds and large institutions have $13.9M invested in BioLineRX in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.

Holders
24
Holders Change
-7
Holders Change %
-22.58%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$519K
2
DG
2
Delek Group
Israel
$134K
3
NFG
3
Next Financial Group
Texas
$27K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$31K
5
DWM
5
Doyle Wealth Management
Florida
$1K

Top Sellers

1
EMG
1
ETF Managers Group
New Jersey
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
SM
3
Sabby Management
Florida
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
VF
5
Virtu Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EMG
26
ETF Managers Group
New Jersey
– -$157K -607 Closed
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
– -$33K -128 Closed
SM
28
Sabby Management
Florida
– -$16K -62 Closed
Citadel Advisors
29
Citadel Advisors
Florida
– -$14K -56 Closed
VF
30
Virtu Financial
New York
– -$5K -21 Closed
UBS Group
31
UBS Group
Switzerland
– -$5K -20 Closed
PVH
32
Psagot Value Holdings
Israel
– -$3K -11 Closed
1
2